Inventiva S.A. Sponsored ADR

IVA Healthcare Biotechnology

Inventiva S.A. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $9.0 million, down 43.7% from fiscal 2024.

2.94 0.17 −5.47%
Market cap
$740.0M
P/E
0.0×
Fwd P/E
−4.6×
Dividend yield
—
F-score
4/9
Altman Z
−1.36
Beneish M
−7.91
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — — 3 3 2 2 1 4
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
— — — — 9.33 7.20 0.16 (5.68) (4.53) (1.36)
P/S ratio
0.00 44.07 44.07 44.07 70.80 70.85 9.67 9.26 4.22 9.16
Altman Z″-Score (non-manufacturers)
2.10 — — 1.52 7.61 3.61 0.12 (15.61) (11.56) (4.14)
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Beneish M-Score
— — — — (2.73) (2.33) (3.50) (1.09) (7.35) (7.91)
P/Operating CF
(49.78) (49.78) (49.78) (49.78) (19.22) (36.52) (13.29) (12.57) (1.59) (2.95)
P/B ratio
8.56 8.56 8.56 8.56 4.09 5.28 4.00 0.00 0.00 0.00
EV/Sales
38.86 38.86 38.86 38.86 55.75 59.20 6.88 9.48 6.54 5.41
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/FCF
(5.44) (5.44) (5.44) (5.44) (6.02) (5.23) (1.46) (1.45) (1.22) (0.77)
Current Ratio
4.80 7.46 4.75 3.53 9.56 5.06 3.47 0.96 0.92 3.16
Net Debt/EBITDA
1.57 2.24 1.67 1.24 3.44 1.43 0.94 (0.11) 0.46 0.29
Debt/Equity
0.02 0.01 0.00 0.00 0.09 0.11 0.76 (1.17) (0.51) (2.10)
ROE
(13.22%) (40.99%) (53.16%) (57.77%) (44.29%) (50.59%) (74.72%) (1,804.49%) 265.66% 542.65%
ROA
(10.52%) (89.41%) (53.98%) (43.52%) (34.52%) (38.76%) (42.91%) (121.02%) (195.41%) (194.96%)
ROIC
0.00% 0.00% 0.00% (334.31%) (119.22%) (262.00%) 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(18.73%) (30.42%) (55.28%) (78.02%) (27.47%) (51.75%) (65.34%) (1,543.11%) 4,370.44% (208.23%)
Average Days of Receivables
553.41 521.97 1,523.93 318.00 629.44 359.51 116.54 144.33 135.64 197.88
Earnings Yield
(316.20%) (17.17%) (17.17%) (17.17%) (12.60%) (15.17%) (52.09%) (75.81%) (166.50%) (76.62%)
Free Cash Flow Yield
0.00% (16.21%) (16.21%) (16.21%) (13.09%) (15.97%) (48.84%) (70.80%) (127.43%) (76.47%)
Free Cash Flow per Share
(1.00) (1.32) (1.54) (1.36) (1.04) (1.45) (1.16) (1.96) (1.56) (0.64)
Book value per Share
2.40 4.81 2.78 1.97 3.75 2.68 1.16 (0.76) (1.93) (0.17)
Free Cash Flow
(15.64) (20.48) (39.32) (31.96) (35.28) (56.88) (47.88) (88.77) (93.34) (118.95)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 30 Sep 2026